报告作者：Sabrient    报告出处：Sabrient Leaders In Investment Research
相关股票：$LBIO(LBIO)$

Lion Biotechnologies, Inc. is a biotechnology company. The Company is focused on developing and commercializing adoptive cell therapy (ACT) using autologous tumor infiltrating lymphocytes (TILs) for the treatment of metastatic melanoma and other solid cancers.
网页链接